You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Express Scripts

Last Updated: August 12, 2020

DrugPatentWatch Database Preview

METHOCARBAMOL - Generic Drug Details

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

What are the generic sources for methocarbamol and what is the scope of freedom to operate?

Methocarbamol is the generic ingredient in five branded drugs marketed by Dr Reddys, Marsam Pharms Llc, Am Regent, Aurobindo Pharma Ltd, Fresenius Kabi Usa, Gland Pharma Ltd, Monterey Pharms Llc, Mylan Institutional, Navinta Llc, Sagent Pharms Inc, Slate, Somerset Theraps Llc, Hikma, Ferndale Labs, Forest Labs, Able, Am Therap, Ani Pharms Inc, Ascot, Austarpharma Llc, Beximco Pharms Usa, Clonmel Hlthcare, Dbl Pharms, Fosun Pharma, Granules India Ltd, Heather, Hetero Labs Ltd Iii, Hikma Intl Pharms, Impax Labs, Inwood Labs, Ivax Sub Teva Pharms, Kv Pharm, Lannett Co Inc, Mylan, Nylos, Oxford Pharms, Pioneer Pharms, Prinston Inc, Puracap Pharm, Purepac Pharm, Roxane, Sandoz, Solvay, Sun Pharm Industries, Superpharm, Tablicaps, Upsher Smith, Watson Labs, and Auxilium Pharms Llc, and is included in seventy-one NDAs. Additional information is available in the individual branded drug profile pages.

There are twenty-seven drug master file entries for methocarbamol. Forty-nine suppliers are listed for this compound.


See drug prices for METHOCARBAMOL

Drug Sales Revenue Trends for METHOCARBAMOL

See drug sales revenues for METHOCARBAMOL

Recent Clinical Trials for METHOCARBAMOL

Identify potential brand extensions & 505(b)(2) entrants

Tanta UniversityPhase 3
Boehringer IngelheimPhase 3
Montefiore Medical CenterPhase 4

See all METHOCARBAMOL clinical trials

Pharmacology for METHOCARBAMOL
Medical Subject Heading (MeSH) Categories for METHOCARBAMOL

US Patents and Regulatory Information for METHOCARBAMOL

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Ascot METHOCARBAMOL methocarbamol TABLET;ORAL 087660-001 Oct 27, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
Ivax Sub Teva Pharms METHOCARBAMOL methocarbamol TABLET;ORAL 084648-001 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
Able METHOCARBAMOL methocarbamol TABLET;ORAL 040413-002 Mar 17, 2003 DISCN No No   Start Trial   Start Trial   Start Trial
Oxford Pharms METHOCARBAMOL methocarbamol TABLET;ORAL 040489-001 Jan 29, 2003 AA RX No No   Start Trial   Start Trial   Start Trial
Puracap Pharm METHOCARBAMOL methocarbamol TABLET;ORAL 084231-002 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.